The opening of Cegedim Relationship Management’s office in South-Korea 7 years ago was a derived strategically. Recently Datamonitor forecasted Korea’s pharmaceutical market value as $11.6 billion in revenue for 2010, with a compound annual growth rate (CAGR) of 9.6% for the period spanning 2006 to 2010. In terms of regional segmentation, it accounts for 8.4% of the Asia-Pacific pharmaceuticals market value. In this market, a prescription is required to access most medications. Marketing of prescription drugs by pharmaceutical firms is consequently mainly aimed at medical practitioners, who wield an important influence.
Leveraging Local Growth through Improved Segmentation
Segmentation methodologies are commonly used by pharmaceutical companies to define subsets of customers based on multiple variables and criteria. Sales Force Effectiveness and Commercial Operations managers in South-Korea have shown a growing interest in national network structures to create better targeting and segmentation models. This leading pharmaceutical company searched for a suite of tools that would adequately support their sales and marketing teams with the focus on tools that enable more advanced segmentation methodologies.
Cegedim Relationship Management’s CRM portfolio displays an intuitive graphical user interface to seamlessly manipulate segmentation criteria and variables, giving users the ability to make advanced segmentation adjustments to dynamically improve their queries on-the-go.
“Our proven and tested suite of solutions has now been clearly adapted for a specific market such as South-Korea,” stated Franck Levassort, President Asia Pacific at Cegedim Relationship Management. “Furthermore, the combination of our three portfolio products in Data, CRM and Analytics provides the optimal formula for success.”